Form EFFECT Cidara Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005782 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ivie Realty Announces Expanded Investor Services Through BrokenBowInvestors.com to Support Oklahoma's Growing Short Term Rental Market
- Cheques Hold 22% of Canadian Payment Value in 2024
- Laifen Expands U.S. Retail Footprint with Costco Launch of Best-Selling SE Hair Dryer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share